FDA decision: Cytisinicline by Achieve Life Sciences (June 2026)
FDA decision: Cytisinicline by Achieve Life Sciences (June 2026)
Chance
Denied (CRL Issued)
78%
▲ 57
Denied (CRL Issued)
78%
▲ 57
No Decision
10%
▼ 11
No Decision
10%
▼ 11
Conditional / Accelerated Approval
8%
▼ 7
Conditional / Accelerated Approval
8%
▼ 7
2 more
Market Rules
Denied (CRL Issued)
If the FDA's decision on Cytisinicline by Achieve Life Sciences in June 2026 is Denied (CRL Issued) before Jul 1, 2026, the market resolves to Yes. Outcome verified from AppliedXL.
Note: this event is mutually exclusive.
Timeline and payout
Market openJun 9, 2026 · 6:00pm EDT
Market closesAfter the outcome occurs
Projected payout30 minutes after closing
SeriesKXCYTISINICLINE
EventKXCYTISINICLINE-26
MarketKXCYTISINICLINE-26-DN
Insider trading is prohibited
The following are prohibited from trading this contract:
- Persons who are employed by any of the Source Agencies are not permitted to trade on the Contract.
- Persons who hold any material, non-public information on the Underlying are not permitted to trade on the Contract.